Oxidative Medicine and Cellular Longevity / 2016 / Article / Tab 1

Research Article

Kaempferol Attenuates Myocardial Ischemic Injury via Inhibition of MAPK Signaling Pathway in Experimental Model of Myocardial Ischemia-Reperfusion Injury

Table 1

Effect of KMP on biochemical parameters.

Groups MDA (nmole/g tissue)GSH (µmole/g tissue)SOD (U/mg protein)CAT (U/mg protein) LDH (U/L) CK-MB (U/L)

Sham 63.27 ± 2.50 1.15 ± 0.08 5.48 ± 0.39 6.63 ± 0.38 450.62 ± 28.85414.12 ± 19.84
IR-C 99.97 ± 3.49 0.62 ± 0.04 2.94 ± 0.51 3.87 ± 0.42 742.04 ± 20.00616.64 ± 21.16
KMP 20 + IR 79.04 ± 3.8 0.94 ± 0.06 5.3 ± 0.5 5.91 ± 0.47 589.58 ± 20.02513.18 ± 20.62
KMP 20 ps 67.96 ± 2.81 1.06 ± 0.06 5.33 ± 0.33 6.17 ± 0.3 499.19 ± 20.86466.41 ± 18.42

MDA: malondialdehyde; GSH: reduced glutathione; SOD: superoxide dismutase; CAT: catalase; LDH: lactate dehydrogenase; CK-MB: Creatine Kinase-MB isoenzyme. IR-C: ischemia-reperfusion control; KMP 20 + IR: kaempferol 20 mg/kg/day + ischemia-reperfusion; KMP 20 ps: kaempferol 20 mg/kg/day per se. The values are expressed as mean ± SEM; in each group; , versus sham; ; versus IR-control.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.